Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy [Phase 2]
Phase 2 trial investigating safety and efficacy of QL-007 tablets in combination with entecavir or tenofovir for chronic hepatitis B patient…
-
FDA label_change · 2019-11-06FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons to update the drug’s labeling.
-
FDA approval · 2019-11-06FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C., resulting in updated/expanded…
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study [Phase 4]
Phase 4 trial updating the use of tenofovir disoproxil fumarate (TDF) 300 mg as rescue therapy in chronic hepatitis B with prior nucleos(t)i…
-
FDA approval · 2019-11-04FDA Approved: ENTECAVIR — Original Application (Yaopharma Co., Ltd.)
FDA approved Yaopharma Co., Ltd.'s entecavir as an original application (ANDA212201).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B [Phase 2]
Phase 2 trial update on GS-4774 for chronic hepatitis B reports safety and efficacy results.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: ID HBV Vaccination With Imiquimod in OBI [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating hepatitis B vaccination with imiquimod has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission [Phase 4]
Phase 4 trial update on using Tenofovir to prevent mother-to-child transmission of Hepatitis B.
-
CLINICAL_TRIALS trial_result · 2019-10-03Clinical Trial Update: A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults [Phase 4]
Phase 4 randomized trial comparing different dosages and schedules of a Hepatitis B vaccine in healthy adults; results posted after completi…
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B [Phase 2]
A Phase 2 randomized, placebo-controlled trial evaluating Antroquinonol in patients with chronic hepatitis B; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed [Phase 3]
Phase 3 trial evaluating efficacy and safety of switching virologically suppressed chronic hepatitis B patients from TDF to TAF. Completed w…
-
FDA approval · 2019-09-25FDA Approved: ENTECAVIR — Original Application (EPIC PHARMA, LLC)
FDA approves EPIC PHARMA, LLC's original application for entecavir (ENTECAVIR), a generic antiviral for chronic hepatitis B infection.
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy [Phase 4]
Phase 4 trial evaluating switching or adding pegylated interferon in chronic hepatitis B patients on long-term oral antiviral therapy.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection [Phase 2]
Phase 2 clinical trial update for REP 2139-Mg and REP 2165-Mg combination therapy in Chronic Hepatitis B has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection [Phase 3]
Phase 3 trial evaluating telbivudine in children and adolescents with compensated chronic hepatitis B; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants [Phase 2]
Phase 2 study assessing safety and immunogenicity of a hexavalent DTwP-HepB-IPV-Hib vaccine in healthy infants; status not specified.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment [Phase 2]
Phase 2 trial evaluating add-on peginterferon after nucleos(t)ide analogue therapy for chronic hepatitis B has completed with posted results…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B: [Phase 4]
Phase 4 trial update investigating tenofovir alafenamide with fine-needle aspiration biopsy in chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: A Phase IV Study to Assess the Safety of EupentaTM Inj [Phase 4]
Phase IV study update assessing the safety of EupentaTM Inj; the document lists multiple conditions and an unknown status for the trial.
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue Therapy [Phase 4]
Open-label Phase 4 trial evaluating 48-week Peginterferon alfa-2a for sustained response in chronic hepatitis B patients with HBeAg seroconv…
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy [Phase 4]
Phase 4 trial update evaluating the efficacy of an HBV vaccine as consolidation therapy with nucleos(t)ide analogues in chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients [Phase 4]
Phase 4 trial assessing immunogenicity of Hepatitis B vaccination in patients undergoing methadone maintenance treatment.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir [Phase 4]
Phase 4 trial updates the antiviral efficacy and safety of switching to TAF in adults with chronic hepatitis B who have suboptimal response …
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia [Phase 3]
Phase 3 trial assessing immunogenicity and safety of Infanrix-IPV/Hib given in a three-dose schedule with a booster in healthy infants in Ru…
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection [Phase 2]
Phase 2 multicenter study assessing depth and duration of Hepatitis B surface antigen reduction after ARC-520, with or without Entecavir, in…